SARS-CoV-2 conserved genomic RNA regions (SARS-CoV-2 RNA)

SARS-CoV-2 conserved genomic RNA regions are highly stable and invariant sequences and structural motifs within the viral genome that are essential for the virus's life cycle (Ziv et al., 2020, Nature). These regions include the 5' and 3' untranslated regions (UTRs), the programmed -1 ribosomal frameshifting element (FSE), and specific stem-loop structures like the s2m motif (Lan et al., 2022, Nature Communications). Because these sequences are critical for replication, translation, and packaging, they are less prone to mutation compared to surface proteins like the Spike protein, making them attractive targets for broad-spectrum antiviral therapies (Andrews et al., 2021, ACS Central Science). Therapeutic strategies targeting these regions include antisense oligonucleotides (ASOs), small interfering RNAs (siRNAs), and small molecules designed to bind and stabilize or disrupt specific RNA secondary structures (Zhu et al., 2021, Nucleic Acids Research). By interfering with these conserved elements, drugs can effectively halt viral production and reduce the severity of COVID-19 (Haniff et al., 2020, ACS Central Science). This approach provides a potential safeguard against viral evolution and the emergence of new variants.

Other names

Conserved SARS-CoV-2 RNA elementsSARS-CoV-2 RNA secondary structuresSARS-CoV-2 5' and 3' UTRsProgrammed -1 ribosomal frameshifting elementFSEs2m motifSARS-CoV-2 RNA genome

Antisense oligonucleotides and siRNAs target these regions to trigger RNA degradation via RNase H or the RNA-induced silencing complex (RISC), while small molecules bind to conserved secondary structures to disrupt essential processes like ribosomal frameshifting or viral replication (Zhu et al., 2021, Nucleic Acids Research; Haniff et al., 2020, ACS Central Science). Nucleoside analogs like Molnupiravir are incorporated into the nascent RNA strand, leading to lethal mutagenesis (Jayk Bernal et al., 2022, NEJM).